RNA结合基元蛋白24通过调控HOTAIR表达抑制鼻咽癌细胞增殖

doi:10.3969/j.issn.1004-616x.2020.04.005

癌变·畸变·突变 ›› 2020, Vol. 32 ›› Issue (4): 275-280.doi: 10.3969/j.issn.1004-616x.2020.04.005

RNA结合基元蛋白24通过调控HOTAIR表达抑制鼻咽癌细胞增殖

陈琪¹, 钟茜², 岳文涛¹

1. 首都医科大学附属北京妇产医院中心实验室, 北京 100026;
2. 华南肿瘤学国家重点实验室/中山大学肿瘤防治中心/肿瘤医学协同创新中心, 广东广州 510060

收稿日期:2019-10-24 修回日期:2020-05-31 出版日期:2020-07-31 发布日期:2020-08-01
通讯作者: 岳文涛,E-mail:yuewt@ccmu.edu.cn;钟茜,E-mail:zhongqian@sysucc.org.cn E-mail:yuewt@ccmu.edu.cn;zhongqian@sysucc.org.cn
作者简介:陈琪,E-mail:yqglzhh@163.com。
基金资助:
国家自然科学基金（81502353，81672838）；北京市医院管理局临床技术创新项目（XMLX201705）；首都医科大学附属北京妇产医院中青年学科骨干培养专项（FCYY201713）

Inhibition of nasopharyngeal carcinoma proliferation by RBM24 via regulation of HOTAIR

CHEN Qi¹, ZHONG Qian², YUE Wentao¹

1. Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026;
2. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, Guangdong, China

Received:2019-10-24 Revised:2020-05-31 Online:2020-07-31 Published:2020-08-01

摘要/Abstract

摘要： 目的： 探讨RNA结合基元蛋白24（RBM24）抑制鼻咽癌细胞增殖的可能机制。方法： 分别在永生化鼻咽上皮细胞N5、NP69和鼻咽癌细胞CNE1中转染RBM24 siRNA构建敲低RBM24表达的细胞模型。建模后分别于1~5 d用CCK-8法检测细胞增殖活性，用实时荧光PCR法检测细胞HOX转录反义RNA（HOTAIR）的表达水平。结果： 实时荧光PCR法检测结果表明敲低RBM24表达的细胞模型构建成功。第4天时RBM24敲低组的CNE1、N5细胞增殖率（分别为5.11±0.03和2.09±0.18）与相应的对照组细胞（分别为4.53±0.05和1.73±0.12）相比均升高（P均 < 0.05），且CNE1、N5细胞的HOTAIR mRNA表达水平（分别为67.54±1.87和7.81±1.90）较相应的对照组（1.00±0.21和1.00±0.19）亦升高，差异均有统计学意义（P均 < 0.05），而NP69细胞的增殖率和HOTAIR mRNA表达水平变化不明显（P均 > 0.05）。结论： RBM24可抑制鼻咽癌CNE1细胞和永生化鼻咽上皮N5细胞的增殖，其机制可能是通过抑制HOTAIR表达起作用。

关键词: RNA结合基元蛋白24, 鼻咽癌, 永生化鼻咽上皮细胞, HOX转录反义RNA, 增殖

Abstract: OBJECTIVE: This study aimed to explore mechanisms of RBM24 in inhibition of proliferation in nasopharyngeal carcinoma cells. METHODS: Cell models with RBM24 knocked down were built via RBM24 siRNA transfection into immortalized nasopharyngeal epithelial cells N5, NP69, and nasopharyngeal carcinoma cells CNE1. After the cell models was built,CCK-8 assay was performed to evaluate the effect of transfection on cell proliferation each day from day 1 to 5. Real-time PCR was carried out to evaluate the expression of HOTAIR. RESULTS: Successful modeling of RBM24 knocked down were confirmed by real-time PCR. The knockdown significantly induced proliferation of CNE1 (5.11±0.03) and N5 (2.09±0.18),compared with the control group (4.53±0.05 and 1.73±0.12, respectively). It also upregulated HOTAIR expression in CNE1 (67.54±1.87) and N5 (7.81±1.90), compared with the control group (1.00±0.21 and 1.00±0.19, respectively, all with P < 0.05). But it had no obvious effect on the proliferation and HOTAIR expression in NP69 (all with P > 0.05). CONCLUSION: RBM24 inhibited cell proliferation of nasopharyngeal carcinoma cell CNE1 and immortalized nasopharyngeal epithelial cells N5,through downregulation of HOTAIR expression.

Key words: RBM24, nasopharyngeal carcinoma, immortalized nasopharyngeal epithelial cells, HOTAIR, proliferation

中图分类号:

陈琪, 钟茜, 岳文涛. RNA结合基元蛋白24通过调控HOTAIR表达抑制鼻咽癌细胞增殖[J]. 癌变·畸变·突变, 2020, 32(4): 275-280.

CHEN Qi, ZHONG Qian, YUE Wentao. Inhibition of nasopharyngeal carcinoma proliferation by RBM24 via regulation of HOTAIR[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 275-280.

参考文献

[1] ZHENG X H, LU L X, LI X Z, et al. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China[J]. Cancer Sci, 2015, 106(9):1196-1201.
[2] FUNG S Y, LAM J W, CHAN K C. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma[J]. Chin Clin Oncol, 2016, 5(2):18.
[3] LO A K, LUNG R W, DAWSON C W, et al. Activation of sterol regulatory element-binding protein 1(SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1(LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma[J]. J Pathol, 2018, 246(2):180-190.
[4] ZHENG X, WANG J, WEI L Y, et al. Epstein-Barr virus miR-BART5-3p inhibits p53 expression[J]. J Virol, 2018, 92(23):e01022.
[5] FAN C, TANG Y, WANG J, et al. The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma[J]. J Cancer, 2018, 9(16):2852-2864.
[6] WONG T S, CHEN S, ZHANG M J, et al. Epstein-Barr virus-encoded microRNA BART7 downregulates major histo-compatibility complex class I chain-related peptide A and reduces the cytotoxicity of natural killer cells to nasopharyngeal carcinoma[J]. Oncol Lett, 2018, 16(3):2887-2892.
[7] MA B B Y, CHEN Y P, HUI E P, et al. Recent advances in the development of biomarkers and chemoradiotherapeutic approaches for nasopharyngeal carcinoma[J]. Am Soc Clin Oncol Educ Book, 2020, 40:1-11.
[8] BAKKALCI D, JIA Y, WINTER J R, et al. Risk factors for Epstein Barr virus-associated cancers:a systematic review, critical appraisal, and mapping of the epidemiological evidence[J]. J Glob Health, 2020, 10(1):010405.
[9] OUYANG H, ZHANG K, FOX-WALSH K, et al. The RNA binding protein EWS is broadly involved in the regulation of pri-miRNA processing in mammalian cells[J]. Nucleic Acids Res, 2017, 45(21):12481-12495.
[10] TECHASINTANA P, ELLIS J S, GLASCOCK J, et al. The RNA-binding protein HuR posttranscriptionally regulates IL-2 homeostasis and CD4(+) Th2 differentiation[J]. Immunohorizons, 2017, 1(6):109-123.
[11] HUA W F, ZHONG Q, XIA T L, et al. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma[J]. Cell Death Dis, 2016, 7(9):e2352.
[12] MA D D, YUAN L L, LIN L Q. LncRNA HOTAIR contributes to the tumorigenesis of nasopharyngeal carcinoma via up-regulating FASN[J]. Eur Rev Med Pharmacol Sci, 2017, 21(22):5143-5152.
[13] NIE Y, LIU X, QU S, et al. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival[J]. Cancer Sci, 2013, 104(4):458-464.
[14] AIELLO A, BACCI L, RE A, et al. MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells[J]. Sci Rep, 2016, 6:38414.
[15] WU L, LI C, PAN L. Nasopharyngeal carcinoma:A review of current updates[J]. Exp Ther Med, 2018, 15(4):3687-3692.
[16] PAUL P, DEKA H, MALAKAR A K, et al. Nasopharyngeal carcinoma:understanding its molecular biology at a fine scale[J]. Eur J Cancer Prev, 2018, 27(1):33-41.
[17] ZHANG T, LIN Y, LIU J, et al. Rbm24 regulates alternative splicing switch in embryonic stem cell cardiac lineage differentiation[J]. Stem Cells, 2016, 34(7):1776-1789.
[18] LIN Y, TAN K T, LIU J, et al. Global profiling of Rbm24 bound RNAs uncovers a multi-tasking RNA binding protein[J]. Int J Biochem Cell Biol, 2018, 94:10-21.
[19] ZHANG M, ZHANG Y, XU E, et al. Rbm24, a target of p53, is necessary for proper expression of p53 and heart development[J]. Cell Death Differ, 2018, 25(6):1118-1130.
[20] LIU J, KONG X, ZHANG M, et al. RNA binding protein 24 deletion disrupts global alternative splicing and causes dilated cardiomyopathy[J]. Protein Cell, 2019, 10(6):405-416.
[21] JIANG Y, ZHANG M, QIAN Y, et al. Rbm24, an RNA-binding protein and a target of p53, regulates p21 expression via mRNA stability[J]. J Biol Chem, 2014, 289(6):3164-3175.
[22] XU E, ZHANG J, ZHANG M, et al. RNA-binding protein RBM24 regulates p63 expression via mRNA stability[J]. Mol Cancer Res, 2014, 12(3):359-369.
[23] TSAO S W, WANG X, LIU Y, et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes[J]. Biochim Biophys Acta, 2002, 1590(1/2/3):150-158.
[24] YIP Y L, PANG P S, DENG W, et al. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study[J]. PLoS One, 2013, 8(10):e78395.
[25] LI H M, MAN C, JIN Y, et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase[J]. Int J Cancer, 2006, 119(7):1567-1576.
[26] HAN L, ZHANG H C, LI L, et al. Downregulation of long noncoding RNA HOTAIR and EZH2 induces apoptosis and inhibits proliferation, invasion, and migration of human breast cancer cells[J]. Cancer Biother Radiopharm, 2018, 33(6):241-251.
[27] GUPTA R A, SHAH N, WANG K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature, 2010, 464(7291):1071-1076.
[28] CHANG L, GUO R, YUAN Z, et al. lncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer[J]. Cell Physiol Biochem, 2018, 49(4):1289-1303.
[29] LOEWEN G, JAYAWICKRAMARAJAH J, ZHUO Y, et al. Functions of lncRNA HOTAIR in lung cancer[J]. J Hematol Oncol, 2014, 7:90.
[30] MERCER T R, GERHARDT D J, DINGER M E, et al. Targeted RNA sequencing reveals the deep complexity of the human transcriptome[J]. Nat Biotechnol, 2011, 30(1):99-104.
[31] TSAI M C, MANOR O, WAN Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes[J]. Science, 2010, 329(5992):689-693.
[32] LIU Y W, SUN M, XIA R, et al. LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer[J]. Cell Death Dis, 2015, 6:e1802.

RNA结合基元蛋白24通过调控HOTAIR表达抑制鼻咽癌细胞增殖

Inhibition of nasopharyngeal carcinoma proliferation by RBM24 via regulation of HOTAIR

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵岩, 孙震晓. 二甲双胍抑制人MDA-MB-231细胞增殖及迁移的体外实验研究[J]. 癌变·畸变·突变, 2022, 34(1): 35-39.
[2]	郭照萌, 张华, 张鹏. Orai1对鼻咽癌细胞侵袭和上皮-间充质转化的影响及其机制[J]. 癌变·畸变·突变, 2021, 33(6): 420-425.
[3]	王晓舟, 李洪石, 于溪, 魏宁, 王梓瑛, 赫丽杰. 青藤碱对HPV阳性宫颈癌SiHa细胞增殖和侵袭的影响[J]. 癌变·畸变·突变, 2021, 33(6): 442-445.
[4]	王琛瑶, 梁百慧, 吴锦源, 唐梓涵, 许小文, 尹梓健, 丁雅琼, 方雄钊, 李栢芝, 文姝佚, 程转, 詹涵, 张粤烽, 王泫哲, 何仕龙, 张可洵, 刘雅骐, 周飞, 熊兴东, 白春英, 许丽艳, 李恩民. RAC1对恶性肿瘤的调控作用及其分子机制研究进展[J]. 癌变·畸变·突变, 2021, 33(5): 401-404.
[5]	黄晓华, 牛永东, 石刚刚. 核受体FXR激活对宫颈癌CaSki细胞增殖的抑制效应及其作用机制[J]. 癌变·畸变·突变, 2021, 33(4): 302-306.
[6]	郑珺文, 常晨, 郝佳洁, 蔡岩, 王明荣, 张钰. NEDD4在食管鳞癌中的表达及作用研究[J]. 癌变·畸变·突变, 2021, 33(3): 203-207,224.
[7]	张娜, 范志露, 杨荔艳, 常晨, 蔡岩, 郝佳洁, 王明荣. 食管鳞癌中SERPINB5表达降低的作用机制及其临床意义[J]. 癌变·畸变·突变, 2021, 33(2): 101-109.
[8]	方磊, 杨涛, 盛磊, 木塔力甫·艾买提, 齐鑫鑫, 艾尼娃尔·艾克木, 伊力亚尔·尼加提. 黑种草子总皂苷对人宫颈癌SiHa细胞生物学行为的影响[J]. 癌变·畸变·突变, 2021, 33(2): 143-148,152.
[9]	兰莉, 陈海丽, 徐蕾. RBMS3-AS3对宫颈癌细胞增殖、凋亡和侵袭的影响及作用机制[J]. 癌变·畸变·突变, 2020, 32(6): 438-443.
[10]	林凯煌, 蔡高阳, 刘新城. mTOR抑制剂AZD2014对肝癌细胞的增殖抑制作用及其机制研究[J]. 癌变·畸变·突变, 2020, 32(6): 448-451.
[11]	刘鹏, 白意晓. miR-29a对人胃癌细胞增殖、迁移的影响及其机制研究[J]. 癌变·畸变·突变, 2020, 32(6): 452-456,463.
[12]	许迎剑, 张航, 张建清. 细胞核受体RXRα在2,2',4,4'-四溴二苯醚神经毒性中的作用及其机制[J]. 癌变·畸变·突变, 2020, 32(5): 336-343,349.
[13]	戚玉竹, 刘静, 张国君. 核苷酸酶CD73在恶性肿瘤中作用和调控机制的研究进展[J]. 癌变·畸变·突变, 2020, 32(5): 398-401.
[14]	龙子, 樊隽澍, 吴光源, 王欣, 海春旭. 低剂量双酚A通过调控PPARγ致小鼠糖脂代谢紊乱的研究[J]. 癌变·畸变·突变, 2020, 32(4): 245-255.
[15]	王耀杰, 相晓晗, 韩丽娜, 李军, 霍炳杰, 赵连梅. 中药地锦草乙醇提取物体外抑制胃癌细胞增殖活性及机制研究[J]. 癌变·畸变·突变, 2020, 32(3): 187-193.